The anti-doping organization  that determines a filing failure or a missed test shall submit that information to Wada through adaMS or another system approved by Wada, where it will be made available to other relevant anti-doping organizations.7.2 Review Regarding Adverse Analytical Findings  Upon receipt of an adverse analytical finding, the  anti-doping organization responsible for results management shall conduct a review to determine whether: (a) an applicable tue has been granted or will be granted as provided in the international Standard for Therapeutic Use Exemptions, or (b) there is any apparent departure from the international Standard for Testing and investigations or international Standard for Laboratories that caused the adverse analytical finding.